Certara (NASDAQ:CERT) Sets New 1-Year Low – Here’s What Happened

by · The Cerbat Gem

Certara, Inc. (NASDAQ:CERT – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $9.25 and last traded at $9.44, with a volume of 105418 shares changing hands. The stock had previously closed at $9.78.

Analysts Set New Price Targets

CERT has been the topic of a number of analyst reports. TD Cowen assumed coverage on shares of Certara in a report on Thursday, February 27th. They set a “buy” rating and a $16.00 target price on the stock. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Certara in a report on Thursday, February 27th. Barclays raised their price target on Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. Finally, William Blair reissued a “market perform” rating on shares of Certara in a report on Thursday, February 27th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $15.83.

Get Our Latest Analysis on Certara

Certara Stock Down 2.8 %

The stock has a 50 day simple moving average of $12.22 and a 200-day simple moving average of $11.42. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The firm has a market cap of $1.53 billion, a PE ratio of -47.46, a PEG ratio of 9.29 and a beta of 1.64.

Institutional Trading of Certara

Institutional investors have recently added to or reduced their stakes in the business. Kopion Asset Management LLC lifted its holdings in shares of Certara by 46.0% during the fourth quarter. Kopion Asset Management LLC now owns 555,643 shares of the company’s stock valued at $5,918,000 after purchasing an additional 175,005 shares in the last quarter. Principal Financial Group Inc. raised its stake in Certara by 3.1% during the 4th quarter. Principal Financial Group Inc. now owns 531,445 shares of the company’s stock valued at $5,660,000 after buying an additional 15,739 shares during the last quarter. Vontobel Holding Ltd. purchased a new position in shares of Certara in the 4th quarter worth $1,295,000. Barclays PLC increased its position in Certara by 198.3% during the third quarter. Barclays PLC now owns 70,525 shares of the company’s stock valued at $825,000 after acquiring an additional 46,880 shares during the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in shares of Certara during the 4th quarter valued at about $148,000. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Certara Company Profile

(Get Free Report)

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

See Also